Hey Tommy,
But under ASIC Form 603
Column 1 Column 2 0 Consideration (cash or non-cash) The consideration given for acquiring the relevant interest must be clearly set out.
Details of the consideration must include any and all benefits (monetary or otherwise) that any person from whom a relevant interest was acquired has, or may become entitled to receive, in relation to that acquisition. Details must be included even if the benefit is conditional on the happening of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or their associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired: Note 9 on Form 603.
Note: Brokerage and other transaction costs of the substantial holder that do not represent a benefit to a person from whom the relevant interest was acquired should not be included when setting out the consideration provided for the relevant interest.
Details of the consideration provided must be disclosed with respect to each acquisition of a relevant interest separately. Where the substantial holder’s relevant interests arise from a number of intraday transactions (e.g. multiple on-market purchases), details of the consideration given under each transaction should be provided (not aggregate figures for each day or other specified time period).
Note: This level of information is required so that the market can ascertain the minimum price at which the substantial holder could make a takeover bid for the entity: s621(3).
The description of cash consideration paid must also be expressed precisely, or must be able to be readily calculated with precision—that is, on the basis of an amount per share for each acquisition. For example, it is not sufficient to state that the shares were acquired at a price between $X or $Y, or at a price per share that has been rounded to the nearest whole cent per share.
Where a large number of transactions are to be reported, an annexure should be used.
Should this not then mean that they still need to disclose the price even if its at todays closing price/whenever the deal was signed to move the new holding into a new company? Or is there some sort of takeover exemption?
- Forums
- ASX - By Stock
- STO
- Ann: Becoming a substantial holder - Harbour
Ann: Becoming a substantial holder - Harbour, page-11
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add STO (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.80 |
Change
0.075(1.12%) |
Mkt cap ! $23.02B |
Open | High | Low | Value | Volume |
$6.72 | $6.83 | $6.71 | $15.52M | 2.293M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
33 | 52334 | $6.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.80 | 52625 | 51 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 129176 | 6.920 |
6 | 233123 | 6.910 |
9 | 295156 | 6.900 |
11 | 303505 | 6.890 |
4 | 129828 | 6.880 |
Price($) | Vol. | No. |
---|---|---|
6.940 | 107742 | 9 |
6.950 | 424616 | 27 |
6.960 | 247191 | 13 |
6.970 | 73167 | 4 |
6.980 | 17507 | 1 |
Last trade - 13.40pm 18/11/2024 (20 minute delay) ? |
Featured News
STO (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online